The Industry Alliance Office - acting on behalf of Amsterdam Neuroscience - is a full service shop to the pharma- and biotech-industry for pre-clinical research all the way up to clinical phase III. Over the last 36 months the IAO has commercialized the scientific excellence, research assets, access to patient cohorts and material, and infrastructure based on a disease-orientated approach: Neurodegeneration (AD, FTD, Lewy Body Dementia and Vascular Cognitive Impairment), Neuro-inflammation (MS), Neuro-infection (Meningitis, Chronic Inflammatory Demyelinating Polyneuropathy), Neuropsychiatry (Anxiety and Depression, Psychosis, OCD, PTSD and SZ). The plan for 2016-2019 is to upscale this embedded business development activity to also implement AMC and SILS capacities and services.

The Industry Alliance Office website of Amsterdam Neuroscience can be found here: Industry Alliance Office